SOME ISSUES ON THE USE OF THE MEDICINAL PRODUCT DECACAN IN MEDICINE AND THE MECHANISM OF ACTION

This article discusses the use of the medicinal product Decacan in medicine and the mechanism of action. Decacan accumulates in the cytoplasmic membrane (SPM) of the microbial cell and binds to the phosphatide groups of membrane lipids, disrupts the SPM of microorganisms, and has an antimicrobial and antifungal effect.

Institutions

Samarkand State Medical Institute (UZ)

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2025-01-22
DOI: https://doi.org/10.5281/zenodo.14720771
Primary Topic: Artificial Intelligence in Law
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

SOME ISSUES ON THE USE OF THE MEDICINAL PRODUCT DECACAN IN MEDICINE AND THE MECHANISM OF ACTION

Jan 22, 2025

Zenodo (CERN European Organization for Nuclear Research)

Artificial Intelligence in Law

article

SOME ISSUES ON THE USE OF THE MEDICINAL PRODUCT DECACAN IN MEDICINE AND THE MECHANISM OF ACTION

January 22, 2025article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Samarkand State Medical Institute (UZ)

Openalex Percentile: Top 47%

Artificial Intelligence in Law

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SOME ISSUES ON THE USE OF THE MEDICINAL PRODUCT DECACAN IN MEDICINE AND THE MECHANISM OF ACTION · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS